|Bluelight Research on Ketamine as a Treatment for Depression and PTSD
Bluelight would like to congratulate Tharcila Chaves and her colleagues on their recent publication: The use of ketamine to cope with depression and post-traumatic stress disorder: A qualitative analysis of the discourses posted on a popular online forum. The paper was published in The American Journal of Drug and Alcohol Abuse.
The abstract is quoted below:
Annotated version of the final paragraph in the conclusion of the article is quoted below:
I think we should be proud to have contributed to an article that advocated greater availability of ketamine as a medicine for depression and PTSD.